
LLL3
CAS No. 63972-38-3
LLL3( LLL 3 )
Catalog No. M15430 CAS No. 63972-38-3
LLL3 is a structural analogue of STA-21 that acts as a novel STAT3 inhibitor.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 873 | Get Quote |
![]() ![]() |
50MG | 1782 | Get Quote |
![]() ![]() |
100MG | 2250 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameLLL3
-
NoteResearch use only, not for human use.
-
Brief DescriptionLLL3 is a structural analogue of STA-21 that acts as a novel STAT3 inhibitor.
-
DescriptionLLL3 is a structural analogue of STA-21 that acts as a novel STAT3 inhibitor, inhibits STAT3-dependent transcriptional and DNA binding activities; also inhibits viability of U87, U373, and U251 glioblastoma cells as well as induces apoptosis of these glioblastoma cell lines; exhibits prolonged survival in U87 glioblastoma tumour-bearing mice.
-
In Vitro——
-
In Vivo——
-
SynonymsLLL 3
-
PathwayJAK/STAT Signaling
-
TargetSTAT
-
RecptorSTAT
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number63972-38-3
-
Formula Weight266.252
-
Molecular FormulaC16H10O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(C1=C2C=CC=C1O)C3=CC=CC(C(C)=O)=C3C2=O
-
Chemical Name1-acetyl-5-hydroxyanthracene-9,10-dione
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Fuh B, et al. Br J Cancer. 2009 Jan 13;100(1):106-12.
2. Fossey SL, et al. BMC Cancer. 2009 Mar 10;9:81.
3. Mencalha AL, et al. Cancer Chemother Pharmacol. 2010 May;65(6):1039-46.
molnova catalog



related products
-
Palivizumab
Palivizumab (MEDI 493) is a humanized RSV-specific monoclonal antibody that selectively inhibits epitopes at the F protein A antigenic site of RSV subtypes A and B for the prevention of respiratory syncytial virus infection (RSV).
-
Oleanolic Acid
Oleanolic acid (Caryophyllin) is a natural compound from plants with anti-tumor activities.
-
BP-1-102
An orally bioavailable, small-molecule inhibitor of STAT3 with Kd of 504 nM.